Teva Pharmaceutical Industries, Takeda Pharmaceuticals USA and other defendants were slapped with an antitrust class action Thursday in Pennsylvania Eastern District Court. The suit, filed by Faruqi & Faruqi, Berger Montague and other law firms, accuses the defendants of conspiring to monopolize the market for the gout medication Colcrys. Counsel have not yet appeared for the defendants. The case is 2:21-cv-03500, Value Drug Company v. Takeda Pharmaceuticals, U.S.A., Inc. et al.
Biotech & Pharmaceuticals
August 05, 2021, 7:29 PM